After taking a day for reflection on her sons' lives with DMD, columnist Betty Vertin says she feels more on top of their care.

CureDuchenne is investing $1 million in Entos Pharmaceuticals to support the development of a new DMD gene therapy.

Shalom Lim is a University of Liverpool graduate, having completed an honors bachelor’s degree in criminology and security in July 2021. Born with Duchenne muscular dystrophy and diagnosed at 4 months ...

DMD treatment SAT-3247 was safe and well-tolerated, and showed signs of increasing muscle strength in five adults, Satellos ...

A couple of speeches recently helped columnist Betty Vertin newly appreciate how much motherhood has been her life purpose.

Long-term data from Genethon’s GNT0004 Phase 1/2 trial reveal sustained motor function in boys with Duchenne muscular ...

New data demonstrated the benefits of Elevidys, a gene therapy for multiple Duchenne muscular dystrophy, in different age ...

A number of strategies can help to ensure adequate joint care to best manage joint pain and stiffness in Duchenne muscular ...